![Protagenic Therapeutics Inc](/common/images/company/N_PTIX.png)
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.062 | -7.6354679803 | 0.812 | 0.839 | 0.7225 | 4385 | 0.75533899 | CS |
4 | -0.29 | -27.8846153846 | 1.04 | 1.13 | 0.7225 | 13693 | 0.8831251 | CS |
12 | -0.55 | -42.3076923077 | 1.3 | 1.87 | 0.7225 | 15673 | 1.39060329 | CS |
26 | -0.06 | -7.40740740741 | 0.81 | 1.87 | 0.7225 | 12451 | 1.33761651 | CS |
52 | -1.33 | -63.9423076923 | 2.08 | 2.22 | 0.6797 | 11301 | 1.25617155 | CS |
156 | -8.89 | -92.2199170124 | 9.64 | 10.48 | 0.6797 | 79044 | 6.41504232 | CS |
260 | -10.25 | -93.1818181818 | 11 | 19.56 | 0.6797 | 415583 | 11.24505263 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.